ArticleJournal of comparative effectiveness research2026
Cost-effectiveness modeling of mortality risk reduction comparing two fixed-dose combination triple therapies in moderate-to-very severe chronic obstructive pulmonary disease.
Krishnali Parsekar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.